Back to Search
Start Over
Accelerating Human Immunodeficiency Virus Self-Testing in the United States: A Call to Action.
- Source :
-
Clinical Infectious Diseases . May2023, Vol. 76 Issue 9, p1678-1680. 3p. - Publication Year :
- 2023
-
Abstract
- Human immunodeficiency virus (HIV) self-testing has emerged as a tool to increase the proportion of people to know their status. Since the first HIV self-test was approved in 2012 by the US Food and Drug Administration (FDA), global access to HIV self-tests has been bolstered by public-private partnerships to ensure equitable access in low- and middle-income countries. However, no company has applied for FDA clearance in a decade. We highlight the potential benefits to reclassifying HIV self-tests from class III to class II. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 76
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 163536685
- Full Text :
- https://doi.org/10.1093/cid/ciad025